Evidence map›Paper›PMID 27578423›Full record

ArticleJournal of clinical apheresis2017

Collection of hematopoietic CD34 stem cells in rhesus macaques using Spectra Optia.

Lynn D Haynes, Jennifer Coonen, Jennifer Post, Kevin Brunner, Debra Bloom, Peiman Hematti, Dixon B Kaufman

Abstract read
In one paragraph

Article in Journal of clinical apheresis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Helical TomoTherapy Total Lymphoid Irradiation and Hematopoietic Cell Transplantation for Kidney Transplant Tolerance in Rhesus Macaques.Transplant international : official journal of the European Society for Organ Transplantation · 2023
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Lynn D HaynesDepartment of Surgery, University of Wisconsin-Madison School of Medicine and Public Health.
Jennifer CoonenWisconsin National Primate Research Center, University of Wisconsin, Madison, Wisconsin.
Jennifer PostWisconsin National Primate Research Center, University of Wisconsin, Madison, Wisconsin.
Kevin BrunnerWisconsin National Primate Research Center, University of Wisconsin, Madison, Wisconsin.
Debra BloomDepartment of Medicine, University of Wisconsin-Madison School of Medicine and Public Health.
Peiman HemattiDepartment of Medicine, University of Wisconsin-Madison School of Medicine and Public Health.
Dixon B KaufmanDepartment of Surgery, University of Wisconsin-Madison School of Medicine and Public Health.
University of Wisconsin System · USUniversity of Wisconsin–Madison · USWisconsin Division of Public Health · US

Funding

WNPRC Supplemental Request for Nonhuman Primate Enclosures to Equip HIV/AIDS-Related Research FacilitiesP51OD011106 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI Dorota A. Grejner-Brzezinska · 2012 to 2026
$150.7M
Tomotherapy and Hematopoietic Stem Cells For Tolerance to Kidney TransplantsU01AI102456 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KAUFMAN, DIXON B · 2012 to 2022
$19.2M
NIAID NIH HHS U01 AI102456NIH HHS P51 OD011106
6 · The paper itself

Abstract

backgroundNonhuman primates, particularly rhesus macaques, are ideal preclinical large animal models to investigate organ tolerance induction protocols using donor hematopoietic stem cells (HSCs) to induce chimerism. Their relatively small size poses some challenges for the safe and effective collection of peripheral blood HSCs through apheresis procedures. We describe our experiences using the Spectra Optia apheresis unit to successfully obtain HSCs from mobilized peripheral blood of rhesus macaques.

methodMobilization of peripheral blood HSCs was induced using granulocyte stimulating factor (G-CSF) and Mozobil. The Spectra Optia unit was used in 18 apheresis procedures in 13 animals (4.9-10 kg). Animal health was carefully monitored during and after the procedure. Changes in peripheral blood cells before, during and after procedure were determined by complete blood count and flow cytometry.

resultsThe automatic settings of the Spectra Optia unit were applied successfully to the procedures on the rhesus macaque. All animals tolerated the procedure well with no mortality. Mobilization of HSCs were most consistently achieved using 50 μg/kg of G-CSF for 5 days and a single dose of Mozobil on the 5th day, followed by collection of cells 3 h after Mozobil injection. The final apheresis product contained an average of 23 billion total nucleated cells with 47% granulocytes, 3,871 million total CD3 cells and 77 million CD34 cells which resulted in an average of 10 million CD34+ cells/kg of donor weight.

conclusionApheresis of peripheral blood mobilized HSCs in rhesus macaques using Spectra Optia is a safe and effective procedure.

Indexed as

AnimalsAntigens, CD34BenzylaminesBlood Cell CountBlood Component RemovalCyclamsFeasibility StudiesFlow CytometryGranulocyte Colony-Stimulating FactorHematopoietic Stem Cell MobilizationHematopoietic Stem CellsHeterocyclic CompoundsMacaca mulattaPeripheral Blood Stem CellsAntigens, CD34BenzylaminesCyclamsGranulocyte Colony-Stimulating FactorHeterocyclic Compoundsplerixaforapheresischimerismprimate

Identifiers

PMID27578423
PMCPMC5332349
OpenAlexW2523821133

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.